Andy Wilkinson has been chosen to serve as a top-level technical expert on drug product technology and work on multiple projects and programs to support clients in the fill/finish and aseptic processing design space
DPS Group, a global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, has promoted Andy Wilkinson to Director of Aseptic Fill Finish.
Reporting to Werner Greyling, President of US Project Operations, Wilkinson will serve as a top-level technical expert on drug product technology and work on multiple projects and programs to support clients in the fill/finish and aseptic processing design space including feasibility, conceptual, and early BOD project phases. While Andy will be based in Kansas City, he will support all US project operations in current DPS offices across the country and future West Coast locations.
"The promotion of Andy is a strategic move to add more subject matter experts to our leadership team, allowing us to better serve our clients and to develop our professional staff," said Greyling. "DPS remains steadfast in its commitment to stay ahead of the curve related to new technologies and design processes."
With more than 30 years of experience leading projects in the pharmaceutical industry, Wilkinson is the Aseptic Fill Finish subject matter expert for DPS. He is a recognised leader in aseptic processing design, aseptic filling, equipment/process design, installation, qualification, operation, and remediation.
The promotion of Andy is a strategic move to add more subject matter experts to our leadership team
Wilkinson uses his operational and technical experience to develop and implement solutions to achieve excellent client results. His blend of owner-side operations and consulting experience allow him to bring a unique perspective and understanding of clients' needs and market factors to each project. His depth of knowledge spans multiple sectors including human pharma, animal health, 503B compounding pharmacies, generic and branded products and small-scale start-ups.
The new Director received a Bachelor of Arts in Interdisciplinary Studies / Biology from University of Missouri at Columbia. He is a member of the Parenteral Drug Association (PDA).
Serving high-tech industries around the world, DPS Group delivers full-service engineering across a range of disciplines, including project management, procurement, design, construction management, health and safety management, commissioning, qualification, and validation (CQV), and facility start-up.